Posted by Michael Wonder on 05 Dec 2018
Bipartisan senators introduce new drug pricing bill
4 December 2018 - A bill introduced by Senators Chuck Grassley and Ron Wyden will seek to crack down on the tactics used by drug companies like Mylan to overcharge taxpayers for Medicaid rebates.
The bipartisan bill from the incoming chairman and ranking member of the Senate Finance Committee could be a sign the two will seek common ground on drug prices.
The bill would give the Department of Health and Human Services new authority to reclassify a drug and recoup rebates when a manufacturer deliberately misclassifies a drug in order to pay lower rebates.
